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Menyanthes trifoliata L. is a valuable medical plant found in Europe, North America, and Asia, which grows on peat bogs and
swamps. It has long been used in folk medicine as a remedy for various ailments. This is the ﬁrst report to demonstrate the
protective antioxidant and anti-inﬂammatory properties of aqueous methanolic extracts derived from the aerial parts (MtAPV)
and roots (MtRV) of in vitro grown plants on human umbilical vein endothelial cells (HUVECs). It describes the inﬂuence of
the tested extracts on the expression of antioxidant (HO-1, NQO1, NRF2, kEAP1, and GCLC) and inﬂammation-related genes
(IL-1α, IL-1β, IL-6, TNF-α, and IFN-γ) in cells stimulated with H2O2 or LPS, respectively. In addition, M. trifoliata extracts were
found to moderately aﬀect the growth of certain bacterial and fungal pathogens, with the strongest antibacterial eﬀect found
against Pseudomonas aeruginosa and Enterococcus faecalis. M. trifoliata extracts demonstrated protective eﬀects against
mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) damage caused by ROS, decreasing the numbers of mtDNA lesions
in the ND1 and ND2 genes and nDNA damage in the TP53 and HPRT1 genes and reducing cleavage in PARP1- and γ-H2A.X-
positive cells. The root extract of in vitro M. trifoliata (MtRV) appears to have better anti-inﬂammatory, antioxidant,
antimicrobial, and protective properties than the extract from the aerial part (MtAPV). These diﬀerences in biological properties
may result from the higher content of selected phenolic compounds and betulinic acid in the MtRV than in the MtAPV extract.
1. Introduction
Health-promoting properties of plants have been used in the
prevention and therapy of many human diseases for thou-
sands of years. Currently, it is estimated that 300,000 plant
species exist worldwide [1]; however, relatively few have con-
ﬁrmed therapeutic or protective properties. Fortunately,
modern methods and equipment allow much faster and
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more accurate analyses of the resources hidden in plants. It is
well known that they synthesize a large number of metabo-
lites which play important roles, including defense against
herbivores, other plants, or pathogens, and some can be
successfully used in general health care [2–5]. One such
group of extremely valuable plant secondary metabolites is
the polyphenols, which allow the plant to respond to stress
agents. When assimilated through the diet in fruits, vegeta-
bles, tea, or medicinal and culinary herbs, these natural
compounds play a key role in the antioxidant protection of
the human body and are believed to have a signiﬁcant impact
on reducing the risk of cancer or cardiovascular disease [6].
Therefore, there is a need to identity rich sources of these
compounds in nature and study their biological properties.
Menyanthes trifoliata L., Menyanthaceae, oﬀers a lot of
promise. This medicinal plant, commonly known as
Bogbean, occurs in the northern hemisphere, mainly in the
circumpolar temperate zone of Europe, North America, and
Asia [7]. In traditional and folk medicine, its leaves are used
to treat lack of appetite, scurvy, fevers, and skin disorders.
Extracts obtained from in vitro cultures of this plant have also
been found to induce apoptosis in glioma cells [8]. Studies
have examined the biological properties of its metabolites
[9, 10], and their results indicate thatM. trifoliata is a source
of phenolics or ﬂavonols [11], some of which, such as pheno-
lic acids, scopoletin, rutin, or loganin, may have potential
medical applications [12–14].
The aim of this work is to determine the antioxidant, anti-
inﬂammatory, antimicrobial, and DNA-protective eﬀects of
the aerial part and root extracts from Menyanthes trifoliata
plants grown in in vitro culture on Schenk and Hildebrandt
(SH) medium together with various other biological
properties.
2. Materials and Methods
2.1. Plant Material. In vitro shoots of M. trifoliata were
established from seeds as described previously [8]. In the
present study, young leaves, roots, and stems were used
for shoot regeneration. The explants were cultured on
0.8% agar-solidiﬁed Schenk and Hildebrandt (SH) medium
supplemented with 1.0mg/L 6-benzyladenine (6-BA) and
0.1mg/L α-naphthaleneacetic acid (NAA) under the follow-
ing conditions: 16/8-hour light/dark photoperiod; light
intensity, 40 μmolm-2 s-1; and temperature, 26°C. Light
green calli were observed after 14 days on the surface of
explants; these were then transferred to SH medium with
4.0mg/L 6-BA and 0.3mg/L NAA for shoot induction.
After four weeks, the shoots obtained from calli were trans-
ferred to SH rooting medium supplemented with 0.3mg/L
6-BA and 1.0mg/L NAA. After two weeks, rooted young
plants were transferred to solid SH medium without growth
regulators and cultured under the conditions described
above. In M. trifoliata in vitro, propagation steps are shown
in Figures 1(a)–1(d).
2.2. M. trifoliata Aerial Part and Root Extract Preparation.
The plant extracts from aerial parts and roots ofM. trifoliata
plants grown in vitrowere prepared according to Sitarek et al.
[15]. Brieﬂy, 10 g of dry weight of aerial parts and roots was
used for extraction. The plant material was extracted for 15
minutes with 80% (v/v) aqueous methanol (500mL) at
35°C using an ultrasonic bath and then for 15 minutes with
300mL of the same solvent. Finally, the extracts were ﬁltered,
evaporated under reduced pressure, lyophilized to dryness,
and then kept dry in the dark until further use. The yields
(w/w) of the extracts were 52.8% and 50.4% of initial plant
dry weight for aerial parts (MtAPV) and roots (MtRV) of
M. trifoliata plants, respectively.
2.3. Phytochemical Analysis of Extracts of M. trifoliata Aerial
Parts and Roots. The phenolic compounds and betulinic acid
were examined in MtAPV and MtRV extracts by HPLC
(Dionex, Sunnyvale, USA) according to Kowalczyk et al. [8].
2.4. Cell Cultures.All experiments were performed on human
umbilical vein endothelial cells (HUVECs). These cells were
purchased from Gibco (Cascade Biologics®, catalog number
C0035C) and cultured in Medium 200 (Gibco, catalog num-
ber M-200-500) supplemented with Low Serum G Growth
Supplement Kit (LSGS Kit; Gibco, catalog number S003K)
at 37°C and 5% CO2 in an incubator (Galaxy® 170 R-CO2
Incubator, New Brunswick Scientiﬁc) under a humidiﬁed
atmosphere.
2.5. Cell Viability. The MTT assay was employed to measure
the viability of HUVECs treated with diﬀerent concentra-
tions of LPS or H2O2 and the MtRV and MtAPV extracts
of M. trifoliata plants grown in vitro. Brieﬂy, cells were
seeded at 1 × 104 cells per well in 96-well culture plates and
were left overnight before being treated for attachment. The
cells were incubated for 24 hours with MtRV and MtAPV
extracts over the concentration ranges 0-5mg/mL. The
inﬂammatory process was initiated with 1 μg/mL LPS, and
separately, the antioxidant response was stimulated with
50μMH2O2. In the next experiment, the cells were incubated
with 1mg/mL MtRV and MtAPV extracts or pretreated with
LPS or H2O2 for one hour and then treated with plant
extracts for 24 hours. After completing the incubation, the
cells were washed once and incubated with 0.5mg/mL of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) at 37°C for four hours. The MTT was then care-
fully removed and DMSO (100 μL) added to each well. The
mixture was vortexed at low speed for ﬁve minutes to fully
dissolve the blue crystals. Absorbance was measured at
570 nm with a reference at 630nm using a BioTek Synergy
HT Microplate Reader (BioTek Instruments, Winooski, VT,
USA). Independent experiments were repeated in triplicate.
Cell viability was expressed as a percentage relative to the
untreated (control) cells, which was deﬁned as 100%.
2.6. Gene Expression. HUVECs were ﬁrst incubated in the
presence of LPS or H2O2 for one hour and then with
1mg/mL MtRV and MtAPV extracts for 24 hours. Total
RNA was then extracted using an ISOLATE II RNA Mini
Kit, according to the manufacturer’s instructions. cDNA
was synthesized from total RNA using a High-Capacity
cDNA Reverse Transcription Kit. A sample of 1 ng total
RNA was used as a template in a total volume of 10 μL,
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following the manufacturer’s instructions. Next, gene expres-
sion was analyzed by TaqMan Probe-Based Real-Time PCR
Assay. TaqMan probes (Life Technologies) were used to ana-
lyze 10 genes (HO-1, NQO1, kAEP1, GCLC, IL-1α, IL-1β, IL-
6, TNF-α, and IFN-γ), and beta actin (ACTB) was included as
the reference gene. qRT-PCR was performed using TaqMan®
Real-Time PCR Master Mix (Life Technologies) and a
CFX96™ Real-Time PCR Detection System (Bio-Rad Labo-
ratories, Hercules, CA, USA) working on CFX Manager™
Software (version 3.1). The thermal cycling conditions were
as follows: 10 minutes of polymerase activation at 95°C,
followed by 40 cycles of 30 s denaturation at 95°C and 60 s
annealing/extension at 60°C. Each sample was run in tripli-
cate. The basal expression level was calculated using the Ct
method [16].
2.7. Determination of Nuclear DNA (nDNA) Damage and
Mitochondrial DNA (mtDNA) Damage. Total genomic
DNA (nuclear and mitochondrial) was isolated from cells
treated with 1mg/mL MtRV and MtAPV extracts for 24 h
and then treated with 50 μM H2O2 for one hour using a
QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA)
according to the manufacturer’s instructions. DNA concen-
trations were determined by spectrophotometric measure-
ment of absorbance at 260 nm, and the purities were
calculated by the A260/A280 ratio using a BioTek Synergy
HT Microplate Reader (BioTek Instruments, Winooski, VT,
USA). The semilong run quantitative RT-PCR (SLR-qRT-
PCR) was used to assess mitochondrial DNA (mtDNA)
and nuclear DNA (nDNA) damage, as described previously,
with some modiﬁcations [17]. All conditions were described
previously [18].
2.8. Cytoplasmic ROS and Mitochondrial ROS Detection. The
cells were incubated with 1mg/mL MtRV or MtAPV for 24
hours and then with 50 μM H2O2 for one hour. DCFDA
(molecular probe, Life Technologies) staining was used to
detect cytoplasmic ROS. DCFDA was diluted to a 5μmol/L
ﬁnal concentration with Hanks’ balanced salt solution
(HBSS), which was incubated with the cells at 37°C for 30
minutes. A MitoSOX Red mitochondrial superoxide indica-
tor was used to measure mitochondrial ROS production.
The indicator was diluted to a 5 μmol/L ﬁnal concentration
with HBSS, which was applied to incubate cells at 37°C for
30 minutes. The cells were washed three times with HBSS.
The ﬂuorescence emission was measured using a BioTek
Synergy HT Microplate Reader. Each sample was run in
triplicate.
(a) (b)
(c) (d)
Figure 1: Subsequent stages ofMenyanthes trifoliata regeneration. (a) Callus formation on the root after 20-day incubation on SH medium
with 1.0mg/L (6-BA) and 0.1mg/L (NAA). (b) Regenerated shoot formed on SH medium with 4.0mg/L 6-BA and 0.3mg/L NAA. Fourth
week of incubation. (c) Rooted young plants grown on SH medium supplemented with 0.3mg/L 6-BA and 1.0mg/L NAA before transfer
to fresh solid SH medium. (d) Regenerated plant grown on solid SH medium without growth regulators after ﬁve weeks. Bar = 1 cm.
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2.9. Analysis of Cellular Phosphorylated H2A.X and Cleaved
PARP Levels. HUVECs were plated in a six-well plate at a
density of 2 × 105 viable cells. The following day, the cells
were treated with MtRV and MtAPV extracts (1mg/mL)
for 24 h and then incubated with 50 μM H2O2 for one hour.
After incubation, the cells were collected, and phosphory-
lated H2A.X- and cleaved PARP-positive cells were detected
using the Apoptosis, DNADamage and Cell Proliferation Kit
(BD Pharmingen, 562253) according to the protocol given by
the manufacturer. The cells were analyzed with a FACSCanto
II cytometer (Becton Dickinson, San Jose, California, USA).
2.10. Antimicrobial Activity. The following strains were
tested: Staphylococcus aureus (ATCC 25923), Enterococcus
faecalis (ATCC29212), Escherichia coli (ATCC 25922),
Pseudomonas aeruginosa (ATCC 27853), and the yeasts
Candida albicans (ATCC 10231) and Saccharomyces cerevi-
siae (ATCC 2601). The growth conditions of all the tested
microorganisms were described previously by Sitarek el al.
[19]. MtRV and MtAPV extracts were used in this study.
The minimum inhibitory concentration (MIC) and the
Minimum Bactericidal/Fungicidal Concentration (MBC or
MFC) of the tested extract were determined as detailed pre-
viously [19].
2.11. Data Analysis. The statistical analysis was performed
using GraphPad Prism 5. All experimental values presented
in this study were expressed as mean ± standard deviation
(SD). The Shapiro-Wilk test to analyze the normality of the
distribution of results was used. Next, the results were ana-
lyzed for equality of variance using Levene’s test. Signiﬁcant
diﬀerences were identiﬁed using the ANOVA test for multi-
ple comparisons, followed by the Dunnet post hoc test.
3. Results
3.1. Chemical Composition of Aerial Part (MtAPV) and Root
Extracts (MtRV) of M. trifoliata Plants. The following pheno-
lic compounds have previously been identiﬁed in MtRV and
MtAPV extracts: chlorogenic acid (177 and 258 μg/g dry
weight, respectively), ellagic acid (518 and 451μg/g dry
weight, receptively), sinapinic acid (146 and 71 μg/g dry
weight, respectively), syringic acid (114μg/g dry weight and
not detected, respectively), rutin (256 and 153μg/g dry
weight, respectively), and also pentacyclic triterpene-
betulinic acid (5437 and 395μg/g dry weight, respectively)
[8]. The main components of the plant extracts are presented
in Table 1.
3.2. Eﬀects of MtAPV and MtRV Extracts on Cell Viability.
Our results showed that the MtRV and MtAPV extracts of
M. trifoliata plants did not present any cytotoxic eﬀect on
the human umbilical vein endothelial cells (HUVECs) in
the tested concentrations (0-5mg/mL) after 24-hour incuba-
tion (Figure 2).
In further experiments, 1 μg/mL LPS or 50μMH2O2 was
used: these values did not exhibit 50% growth inhibition
(IC50 value) of cells and were used for the induction of
inﬂammation or antioxidant eﬀect, respectively (data not
shown). In addition, the eﬀect on cell viability was deter-
mined for both extracts of M. trifoliata in combination with
LPS or H2O2. It was found that the HUVECs demonstrated
no signiﬁcant diﬀerence in cell viability following treatment
with MtRV or MtAPV extracts alone, MtRV or MtAPV in
combination with H2O2, and also MtRV or MtAPV in
combination with LPS (Figure 3).
Table 1: Chosen secondary metabolites of aerial parts (MtAPV)
and roots (MtRV) ofMenyanthes trifoliata plants grown in vitro [8].
Compounds
MtRV MtAPV
μg/g dry weight
Betulinic acid 5437:15 ± 141:33 395:31 ± 14:50
Chlorogenic acid 177:34 ± 9:57 257:9 ± 14:70
Ellagic acid 518:11 ± 26:46 450:65 ± 14:22
Rutin 256:20 ± 3:24 152:99 ± 6:24
Sinapinic acid 146:53 ± 7:03 71:16 ± 3:34
Syringic acid 113:80 ± 0:80 n.d.
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Figure 2: Cell viability after 24-hour treatment of MtRV and
MtAPV extracts of M. trifoliata plants at concentrations of 0-
5mg/mL on HUVECs. Data are presented as mean ± SD.
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Figure 3: Cell viability after 24-hour treatment of HUVECs with
1mg/mL of M. trifoliata MtRV and MtAPV extracts and
pretreatment with LPS and H2O2. Data are presented as mean ± SD.
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3.3. Gene Expression. Quantitative real-time RT-PCR was
used to measure mRNA levels of the antioxidant genes HO-
1, NQO1, NRF2, kAEP1, and GCLC and inﬂammation genes
IL-1α, IL-1β, IL-6, TNF-α, and IFN-γ after treatment with
50 μM H2O2 or 1μg/mL LPS for one hour and after treat-
ment with the MtRV or MtAPV extract of M. trifoliata for
24 hours. Our results demonstrated that treatment with both
extracts at a concentration of 1mg/mL was able to change
the level of antioxidant genes in H2O2-stimulated
HUVECs compared to the controls. Similar results were
obtained for inﬂammatory genes. All the tested genes in
the LPS-stimulated cells demonstrated changes in expres-
sion following treatment with either extract compared to
controls, but better anti-inﬂammatory properties were
observed for the MtRV extract. The results are shown in
Figures 4(a) and 4(b).
3.4. Quantiﬁcation of Nuclear DNA (nDNA) and
Mitochondrial DNA (mtDNA) Damage. mtDNA and nDNA
damage was examined by SLR-qRT-PCR ampliﬁcation of
DNA isolated from HUVECs exposed to MtRV or MtAPV
extracts for 24 hours and then 50 μM H2O2 for one hour.
The cells exposed to 50μM H2O2 demonstrated a signiﬁcant
increase in lesion rate in the ND1 and ND5 regions: about ﬁve
lesions per 10kb DNA. Similarly, the same cells demonstrated
an increase in lesion rate in the HPRT1 and TP53 regions of
nDNA: about ﬁve lesions per 10kb DNA were observed. In
the cells, 24-hour treatment with MtRV or MtAPV extracts
was found to bestow a protective eﬀect against mtDNA and
nDNA damage by decreasing the mtDNA lesion number in
the ND1 and ND5 genes and nDNA damage in the TP53
and HPRT1 genes (Figures 5(a)–5(d)).
3.5. Cytoplasmic ROS and Mitochondrial Superoxide
Generation Detection. Cytoplasmic and mitochondrial ROS
levels were measured after 24-hour treatment with MtRV
and MtAPV (1mg/mL) extracts and then one-hour treat-
ment with 50 μM H2O2. Following 24-hour treatment with
either tested extract, decreased cytoplasmic and mitochon-
drial ROS levels were observed compared to the cells treated
with only H2O2, indicating the presence of a protective eﬀect
(Figures 6(a) and 6(b)).
3.6. Assessment of PARP1- and γ-H2A.X-Positive Cell Levels
by Flow Cytometry after Treatment with MtAPV and MtRV
Extracts. The levels of γH2A.X- and cleaved poly (ADP-
ribose) polymerase 1- (PARP1-) positive cells were evaluated
to determine the protective eﬀect of MtRV and MtAPV
extracts on HUVECs induced by 50 μM H2O2. It was found
that the HUVECs treated with 50μM H2O2 generated a
higher level of γH2A.X- and cleaved PARP1-positive cells
than untreated cells. In turn, 24-hour incubation of cells with
MtRV and MtAPV extracts demonstrated a protective eﬀect
on cells following treatment with 50μM H2O2, reﬂecting a
signiﬁcantly lower percentage of γH2A.X- and cleaved
PARP1-positive cells. Although both extracts demonstrated
a protective eﬀect, better results were observed for the MtRV
extract (Figures 7(a) and 7(b)).
3.7. Assessment of Antimicrobial Activity of MtAPV and
MtRV Extracts. The antimicrobial activity of MtRV and
MtAPV extracts against Staphylococcus aureus, Pseudomonas
aeruginosa, Escherichia coli, Enterococcus faecalis, Saccharo-
myces cerevisiae, and Candida albicans was screened using
MIC and MBC/MFC methods. Both the tested extracts
showed moderate antimicrobial activity (Table 2) against
various strains at a range of MIC values (150-925 μg/mL)
and for MBC/MFC (500-2500μg/mL). The MtRV extract
showed better activity than the MtAPV extract against P.
aeruginosa and E. faecalis, with a MIC value of 150μg/mL.
The MtRV extract demonstrated also better antifungal activ-
ity than the MtAPV extract for C. albicans and S. cerevisiae,
with MIC values of 625μg/mL and 725μg/mL, respectively,
and with MFC values of 625μg/mL and 1500μg/mL,
respectively.
4. Discussion
Plants are well-known to have beneﬁcial eﬀects on human
health. Their extraordinary wealth of biologically active com-
pounds makes them indispensable for human life and allow
the prevention of many civilization diseases. One plant spe-
cies that contains many valuable biologically active com-
pounds is Menyanthes trifoliata. Extracts and infusions of
this plant are used as anti-inﬂammatory, diuretic, or cleans-
ing agents, becoming an important element of phytomedi-
cine [20].
This work is the ﬁrst to demonstrate the protective prop-
erties of M. trifoliata extracts derived from aerial parts and
roots of plants cultivated in vitro. It examines the anti-
inﬂammatory and antioxidant properties of M. trifoliata
extracts (MtRV and MtAPV extracts) in human umbilical
vein endothelial cells (HUVECs) which had previously been
treated with LPS or H2O2. Inﬂammation is a very complex
physiological phenomenon developing in the tissue under
the inﬂuence of diﬀerent stimuli and is mediated by a wide
range of speciﬁc components. It involves interactions
between signal molecules produced by leukocytes, macro-
phages, and mast cells, as well as by the activation of com-
plements [21–23]. A range of studies describe the anti-
inﬂammatory properties of plant extracts against a wide
spectrum of normal and cancer cells [24–26].
One of the aims of the study was to investigate the anti-
inﬂammatory properties ofM. trifoliata extracts on HUVECs
following stimulation by lipopolysaccharide (LPS) for 24
hours. LPS is the main component of the outer membrane
of Gram-negative bacteria. It activates mononuclear phago-
cytes and other cell types by toll-like receptor 4 to promote
the secretion of inﬂammatory mediators including TNF-α,
IL-6, and IL-1β [27]. It was found that the aerial part
(MtAPV) and root (MtRV) extracts of in vitro-derived M.
trifoliata exhibit an anti-inﬂammatory eﬀect by decreasing
the expression of selected genes encoding inﬂammation-
associated cytokines (IL-1α, IL-1β, IL-6, TNF-α, and IFN-γ).
Many reports indicate that M. trifoliata is a source of
phenolic compounds such as coumarins, ﬂavonols, or iri-
doids [11]. Our previous study also showed the presence of
various phenolic compounds in the extracts of in vitro- and
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Figure 4: (a) mRNA expression of antioxidant genes after 24-hour treatment of MtRV andMtAPV extracts (1mg/mL) ofM. trifoliata plants
and stimulation with 50 μMH2O2. (b) mRNA expression of inﬂammatory genes after 24-hour treatment with MtRV and MtAPV extracts of
M. trifoliata plants and 1 μg/mL LPS. ∗For comparison control vs. MtAPV and MtRV extracts. #For comparison MtAPV vs. MtRV extracts.
ACTB served as the reference gene. Data are presented as mean ± SD (n = 3).
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in vivo-derivedM. trifoliata plants, with the content of ellagic
acid (299-518 μg/g dry weight), chlorogenic acid (129-
258μg/g dry weight), and rutin (82-256μg/g dry weight)
varying according to the plant part and growth conditions.
Betulinic acid, a pentacyclic triterpene, was found at its
highest concentrations in the roots of plants derived from
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Figure 5: Quantiﬁcation of nuclear DNA (nDNA) (a, b) and mitochondrial DNA (mtDNA) (c, d) lesion frequency per 10 kb DNA by SLR-
qRT-PCR ampliﬁcation of total DNA from human umbilical vein endothelial cells exposed to MtRV and MtAPV (1mg/mL) extracts for 24
hours followed by 50μM H2O2 for one hour.
∗For comparison control vs. MtAPV and MtRV extracts. #For comparison MtAPV vs. MtRV
extracts. Data represent the mean ± SD of three replicates.
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Figure 6: The production of ROS in human umbilical vein endothelial cells exposed to MtRV andMtAPV extracts ofM. trifoliata (1mg/mL)
for 24 hours followed by 50μM H2O2 for one hour, measured using the probes: DCFDA (a) and MitoSOX (b).
∗For comparison control vs.
MtAPV and MtRV extracts. #For comparison MtAPV vs. MtRV extracts. Results represent means ± SD.
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in vitro cultures. The anti-inﬂammatory and antioxidant
activity of this plant compound is also well documented
in literature [28–30].
Our present ﬁndings indicated that the tested M. trifo-
liata extracts bestow a DNA-protective eﬀect on the tested
cell line. We speculate that betulinic acid and the identiﬁed
phenolic acids (syringic acid, sinapinic acid, ellagic acid,
and chlorogenic acid) may be responsible for this positive
eﬀect, especially as betulinic acid and sinapinic acid have
been found to suppress inﬂammatory cytokines such as IL-
6 or TNF-α [31, 32]. Betulinic acid (lupane-type triterpene)
exhibits a protective eﬀect on mice exposed to lethal doses
of LPS and causes a reduction of LPS-induced TNF-α pro-
duction. In addition, betulinic acid is also known as an inhib-
itor of IFN-γ production [33]. Kim et al. report the
compound to be an anti-inﬂammatory agent acting via inhi-
bition of the nuclear factor-κB (NF-κB) pathway. Similarly,
suppression of tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), and interleukin-1β (IL-1β) was demon-
strated in LPS-activated RAW 264.7 macrophages after betu-
linic acid treatment [34]. Similar properties have also been
described for sinapinic acid [35–37], ellagic acid [38], or
chlorogenic acid [39].
The present study also analyzes the inﬂuence of the two
M. trifoliata extracts on oxidative stress-related gene expres-
sion. Changes in the expression of genes encoding heme
oxygenase 1 (HO-1), quinone dehydrogenase 1 (NQO1),
nuclear factor (erythroid-derived-2)-like-2 (NRF2), Kelch-
like ECH-associated protein 1 (kEAP1), or glutamate-
cysteine ligase catalytic subunit (GCLC) cast light on the
protective role played by the components of the tested
extract in H2O2-stimulated cells. The MtRV and MtAPV
extracts, administered at 1mg/mL, were found to inﬂuence
the expression of HO-1, NRF2, kEAP1, NQO1, and GCLC
genes in H2O2-stimulated HUVECs, with the MtRV extract
demonstrating better protective properties than the
MtAPV.
Previous studies provide a wealth of information describ-
ing the cytoprotective eﬀect of plant phenolic compounds on
HUVECs [40–42]. Some aﬀect the expression of oxidative
stress-related genes; for example, those contained in the
green tea extract increase the mRNA level of heme
oxygenase-1 (HO-1) in human aortic endothelial cells [43],
while the polyphenolic antioxidant fraction from Nymphaea
nouchali leaves increases HO-1 and Nrf2 level in RAW 264.7
cells [44]. Recently, special attention has been paid to the
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Figure 7: Diagrams presented percentage of H2A.X phosphorylation- (a) and cleaved PARP1- (b) positive human umbilical vein endothelial
cells after 24-hour exposure to MtRV and MtAPV extracts followed by 50μM H2O2 for one hour.
∗For comparison control vs. MtAPV and
MtRV extracts. #For comparison MtAPV vs. MtRV extracts. The values represent mean ± SD of three independent experiments.
Table 2: Antimicrobial activity of MtRV and MtAPV extracts of M. trifoliata. Van: vancomycin; NOR: norﬂoxacin; ANF: amphotericin B.
Data represent the median values in triplicate.
Plant
material
Staphylococcus
aureus
Pseudomonas
aeruginosa
Escherichia coli
Enterococcus
faecalis
Saccharomyces
cerevisiae
Candida albicans
MIC
(μg/mL)
MBC
MIC
(μg/mL)
MBC
MIC
(μg/mL)
MBC
MIC
(μg/mL)
MBC
MIC
(μg/mL)
MFC
MIC
(μg/mL)
MFC
Mt RV
extract
225 >500 150 >500 250 >500 150 >500 725 625 625 1500
Mt APV
extract
250 >500 250 >500 250 >500 250 >500 725 725 925 2500
Positive
control
7.82 VAN >500 <0.48 NOR >500 0.98 NOR >500 1.95 VAN >500 <0.48 ANF >5000 <0.48 ANF >5000
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close relationship between inﬂammation and oxidative stress.
The appearance of an excessive amount of free radicals reacts
with cell membrane fatty acids, proteins, or DNA, leading to
mutation and consequently to the development of many dis-
eases. In this context, searching for natural components that
protect cells from adverse changes is extremely desirable.
The present study also tested cytoplasmic and mitochon-
drial ROS levels in H2O2-stimulated HUVECs after treat-
ment with MtRV and MtAPV extracts. Our results,
obtained with dichloro-dihydro-ﬂuorescein diacetate and
red mitochondrial superoxide indicator (MitoSOX), found
the plant extracts to exert a protective eﬀect by decreasing
cytoplasmic and mitochondrial ROS levels in cells. The
MtRV extract demonstrated a stronger antioxidant eﬀect
than the MtAPV extract. It is known that ROS are produced
in epithelial cells by many enzymes, including nicotinamide
adenine dinucleotide phosphate oxidase (NOX), nitric oxide
synthase (NOS), or xanthine oxidase (XOD), as well as the
respiratory chain complex [45]. ROS are extremely impor-
tant elements that play a crucial role in the initiation of
inﬂammatory processes. Elevated levels of ROS produced
by polymorph nuclear neutrophils (PMN) at the site of
inﬂammation can lead to epithelial cell dysfunction and
consequent tissue damage [46]. A considerable body of evi-
dence indicates that the excessive cellular production of
ROS may be closely related to the induction of inﬂammation
and consequently aﬀect the development of diseases such as
Alzheimer’s, Parkinson’s, or cancer [47]. Our ﬁndings con-
ﬁrm that M. trifoliata extracts exhibit protective antioxidant
properties, probably due to the presence of identiﬁed pheno-
lic compounds and pentacyclic triterpenes, such as betulinic
acid, which is consistent with literature data [48]. It should
also be noted that the MtRV extract appears to oﬀer the
strongest cytoprotective eﬀects.
Nuclear and mitochondrial DNA damage was also
quantiﬁed by SLR-qRT-PCR ampliﬁcation of DNA from
HUVECs exposed to plant extracts followed by 50 μM
H2O2. Both extracts were found to have a protective eﬀect,
resulting in a decrease in the lesion rate for all the tested
nuclear and mitochondrial DNA regions after incubation
with MtRV and MtAPV extracts compared to cells incu-
bated only with 50μM H2O2. Although mitochondrial and
nuclear DNA damage, and hence the protective eﬀects of
the tested extracts, can be detected by various methods such
as Southern blot analysis or comet assay, the present study
used a semilong run RT-PCR-based assay. Also, the MtRV
extract demonstrated a stronger protective potential against
ROS-derived DNA damage than the MtAPV extract.
Plant phenolic compounds are known to bestow a pro-
tective eﬀect on DNA against various physical or chemical
factors [49–51]. A similar study investigating the protective
eﬀect of Salvia oﬃcinalis and Thymus vulgaris extracts on
the DNA of HepG2 cells was performed by Kozics et al.
[52]. Their results indicate that H2O2-induced DNA damage
was signiﬁcantly reduced in cells pretreated with both the
tested plant extracts, which were also found to contain
phenolic compounds and betulinic acid. Another study
examined the eﬀect of a puriﬁed Eugenia jambolan leaf and
fruit extract on HepG2 cells; the extracts were found to be
rich sources of many phenolic compounds and betulinic acid
and to exhibit antigenotoxic and antimutagenic eﬀects [53].
Other studies have shown that phenolic compounds,
including phenolic acids, can reduce the level of oxidative
DNA damage in a variety of cell types [54, 55]. However,
the present study is ﬁrst to report the ability of the
in vitro-derived M. trifoliata plant extract to protect cells
against DNA damage. As noted in previous studies, our
results suggest that the protective eﬀect demonstrated by
the examined extracts is related to its phenolic compound
content, including betulinic acid, and the synergy between
extract components.
Flow cytometric analysis showed that M. trifoliata
extracts had a protective eﬀect on the tested cells. HUVECs
treated with H2O2 generated a higher level of γH2A.X- and
cleaved PARP1-positive cells than untreated cells. On the
other hand, 24-hour incubation with the studied MtRV and
MtAPV extracts exhibited a protective eﬀect against pretreat-
ment with H2O2 by reducing the number of γH2A.X- and
cleaved PARP1-positive cells. Poly (ADP-ribose) polymerase
1 (PARP1) is responsible for the ADP-ribosylation process
(PARylation), which is a common posttranslational modiﬁ-
cation of DNA damage. This modiﬁcation regulates many
other biological processes, including the reorganization of
chromatin or DNA damage response (DDR). In addition,
PARP is a substrate for caspases and is cleaved during apo-
ptosis into 86 and 24 kDa fragments [56, 57]. For this reason,
PARP1 acts as a good DNA damage sensor [58]. Similarly,
the H2A.X protein is a key factor in the repair of damaged
DNA and can be phosphorylated on the 139th serine residue
in the presence of DNA damage [59]. Phosphorylated pro-
tein causes a conformational change in the DNA-H2A.X
complex, which allows recruitment of proteins needed to
repair DNA injury [60].
Our results clearly show that M. trifoliata extracts from
plants derived from in vitro cultures play an important role
in DNA protection of the tested cells. This is consistent with
other literature data showing that polyphenol-rich natural
products also inhibit the increases in cleaved PARP level
[61, 62]. Similarly, the level of phosphorylated H2A.X,
another determinant of DNA damage, has previously been
found to be reduced under the inﬂuence of the black tea
or Camptosorus sibiricus extract [63] in other cells. It is
most likely that the phenolic compounds and pentacyclic
triterpene present in the MtRV and MtAPV extracts may
be responsible for the biological eﬀect observed in the
present study.
The study also examines the antibacterial and antifungal
properties of M. trifoliata extracts. The tested MtRV and
MtAPV extracts demonstrated stronger antibacterial than
antifungal action. It was also shown that the MtRV extract
possessed a stronger eﬀect against the tested microorganisms
than MtAPV. The best bacterial growth inhibitory eﬀects
were obtained against Pseudomonas aeruginosa (ATCC
27853) and Enterococcus faecalis (ATCC29212) for the
MtRV extract (MIC = 150 μg/mL). Similar eﬀects were dem-
onstrated for the MtAPV extract against all the tested bacte-
ria (MIC = 250 μg/mL). Also, better fungal growth inhibition
was exhibited by the MtRV extract than the MtAPV extract
9Oxidative Medicine and Cellular Longevity
against Candida albicans (ATCC 10231) and Saccharomyces
cerevisiae (ATCC 2601), where the MIC for Candida albicans
was 625μg/mL. Many plant species naturally produce com-
pounds with antimicrobial or antifungal properties [64–66].
Ivanišová et al. [67] examined the antimicrobial activity of
M. trifoliata leaf extracts, rich sources of polyphenols and
ﬂavonoids, and extracts from other plants against three
Gram-negative bacteria and two Gram-positive species.
TheM. trifoliata extract demonstrated the strongest antibac-
terial activity against Escherichia coli, Salmonella enterica
subsp. enterica, Bacillus thuringiensis, Staphylococcus aureus
subsp. aureus, and Pseudomonas aeruginosa, which corre-
sponds to our results. This study found M. trifoliata to be
the richest source of polyphenols, ﬂavonoids, and phenolic
acids among all the analyzed wild plants in the study. The
antibacterial and antifungal properties of M. trifoliata
extracts have also been investigated by Paudel et al. [68] by
testing their inﬂuence on pathogenic microorganisms such
as S. aureus, E. coli, and C. albicans. In this case, the plant
extracts were active only against S. aureus. The authors attri-
bute these diﬀerences in antimicrobial activity to variations
in antimicrobial metabolites among the tested samples.
The search for new antibacterial compounds has recently
become an extremely important issue due to emerging resis-
tance of pathogens to traditional medicines; in this sense,
plant-derived compounds can play a potentially important
role. They often have speciﬁc chemical structures that can
inhibit bacterial growth through new mechanisms of action
[69]; however, this group of secondary metabolites may also
be of great importance in the development of new com-
pounds against human pathogens. Based on data obtained
in previous studies [70–72], it is likely that betulinic acid
may be chieﬂy responsible for the antibacterial and antifun-
gal eﬀects of the tested extracts [70, 73]. Additionally, we sus-
pect that phenolic acids may have a similar eﬀect and show
synergistic eﬀects with other components, particularly since
the MtRV extract showed the best antimicrobial properties.
Generally, the antibacterial and antifungal mechanism of
action of many phenolic compounds is not yet fully under-
stood [69]. Some studies indicate that they interact with a
range of targets such as DNA, DNA gyrase [74], protein
kinases [75], and helicase, among others [69]. Attempts
should be made to identify new antimicrobial components,
especially as increasing numbers of multidrug-resistant
strains are appearing in the environment [76].
5. Conclusion
The results of our study demonstrate for the ﬁrst time that
MtRV and MtAPV extracts fromM. trifoliata plants derived
from in vitro cultures showed antioxidant and anti-
inﬂammatory eﬀects on human umbilical vein endothelial
cells (HUVECs) stimulated by H2O2 or LPS, and of the
two, the MtRV extract demonstrated the strongest activities.
Additionally, the protective eﬀect was observed which was
associated with a decrease in DNA damage, reductions in
cytoplasmic and mitochondrial ROS levels, and reduced
γH2A.X- and cleaved PARP1-positive HUVEC numbers.
Furthermore, the tested extracts demonstrated moderate
antimicrobial activities against various pathogenic bacterial
and fungal strains. Therefore, this plant may play a potential
role in the therapy and prevention of many civilization
diseases.
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